THERAPY OF TOXOPLASMOSIS UVEITIS.
D000086:Acetazolamide; D000287:Administration, Topical; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002825:Chorioretinitis; D004358:Drug Therapy; D005123:Eye; D006801:Humans; D008775:Methylprednisolone; D009184:Mydriatics; D010656:Phenylephrine; D011239:Prednisolone / Q000008:administration & dosage*; D011739:Pyrimethamine; D013421:Sulfamethoxypyridazine; D014116:Toxicology; D014123:Toxoplasmosis; D014126:Toxoplasmosis, Ocular; D014605:Uveitis
D009184:Mydriatics; D010656:Phenylephrine; D011239:Prednisolone; D000086:Acetazolamide; D001205:Ascorbic Acid; D013421:Sulfamethoxypyridazine; D008775:Methylprednisolone; D011739:Pyrimethamine
ACETAZOLAMIDE; ASCORBIC ACID, THERAPEUTIC; CHORIORETINITIS; DRUG THERAPY; METHYLPREDNISOLONE; MYDRIATICS; PHENYLEPHRINE; PREDNISOLONE, TOPICAL; PYRIMETHAMINE; SULFAMETHOXYPYRIDAZINE; TOXICOLOGIC REPORT; TOXOPLASMOSIS, OCULAR; UVEITIS